SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-22-000031
Filing Date
2022-02-04
Accepted
2022-02-04 07:22:17
Documents
56
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20211231.htm   iXBRL 10-Q 1567420
2 EX-10.1 exhibit101-20211231q3.htm EX-10.1 172191
3 EX-10.2 exhibit102-20211231q3.htm EX-10.2 270854
4 EX-10.3 exhibit103-20211231q3.htm EX-10.3 50884
5 EX-31.1 exhibit311-20211231q3.htm EX-31.1 9611
6 EX-31.2 exhibit312-20211231q3.htm EX-31.2 9512
7 EX-32.1 exhibit321-20211231q3.htm EX-32.1 4557
8 EX-32.2 exhibit322-20211231q3.htm EX-32.2 4578
  Complete submission text file 0001764013-22-000031.txt   5792705

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20211231.xsd EX-101.SCH 29456
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20211231_cal.xml EX-101.CAL 38870
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20211231_def.xml EX-101.DEF 201396
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20211231_lab.xml EX-101.LAB 414318
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20211231_pre.xml EX-101.PRE 283721
50 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20211231_htm.xml XML 629376
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 22590972
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences